Premas Biotech Private Limited - Company Profile

It is a pharma private limited company based in Manesar, Haryana, India, established in 2005.

2005 Manesar, Haryana, India Active

Last Updated: January 05, 2026

About Premas Biotech Private Limited

Premas Biotech Private Limited, a active private limited company, was established on 28 November 2005 in Manesar, Haryana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24232HR2005PTC035932. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹33.50 Cr and a paid-up capital of ₹23.45 Cr.

It upholds a compliant status. Employing 109 professional, Its leadership includes Goutam Das (Director), Prabuddha Kumar Kundu (Managing Director), Nupur Mehrotra (Director). Past directors included John Ernest Siddall, Devendar Agarwal, Narahari Kousik. It holds ₹32.00 Cr open charges and ₹1.00 Cr settled loans. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No-79B & 80B Sector-5, Manesar, Haryana, 122052.

Company Details

CIN/LLPIN
U24232HR2005PTC035932
Registration Number
035932
Incorporation Date
28 November 2005
Authorized Capital
₹33.50 Cr
Paid-Up Capital
₹23.45 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 33.50 Cr as on 05-01-2026
Paid Up Capital ₹ 23.45 Cr as on 05-01-2026
Company Age 20 Year, 2 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 32.00 Cr as on 05-01-2026
Satisfied Charges ₹ 1.00 Cr as on 05-01-2026
Revenue Growth **** -42.93% (FY 2023)
Profit Growth **** -187.10% (FY 2023)
Ebitda **** -183.99% (FY 2023)
Net Worth -15.69% (FY 2023)
Total Assets -12.13% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Premas Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Premas Biotech Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Goutam Das	Director	12 Jul 2012	Current
Prabuddha Kumar Kundu	Managing Director	17 Oct 2011	Current
Nupur Mehrotra	Director	05 Jan 2018	Current
Saumen Chakraborty	Director	29 Apr 2022	Current
Avijit Das	Director	13 Jan 2006	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	20 Mar 2016	Past
Pramod Abcsdd	Company Secretary	20 Sep 2018	Past
Pramod Abcsdd	Additional Director	04 Aug 2009	Past
Pramod Abcsdd	Director	20 Mar 2016	Past
Pramod Abcsdd	Additional Director	26 Sep 2012	Past
Pramod Abcsdd	Company Secretary	30 Sep 2010	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Premas Biotech.

Premas Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.93% decrease. The company also saw a substantial fall in profitability, with a 187.1% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.69%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-42.93%

*******

Revenue from Operations

*******

-37.13%

*******

Total Assets

*******

-12.13%

*******

Profit or Loss

*******

-187.10%

*******

Net Worth

*******

-15.69%

*******

EBITDA

*******

-183.99%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Premas Biotech?

In 2023, Premas Biotech had a promoter holding of 91.44% and a public holding of 8.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹320,000,000.00

Satisfied Charges

₹10,000,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 30.00 Cr
The Hongkong And Shanghai Banking Corporation Limited : 2.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
16 Sep 2022	The Hongkong And Shanghai Banking Corporation Limited	₹2.00 Cr	Open
11 Mar 2022	Hdfc Bank Limited	₹15.00 Cr	Open
07 Sep 2021	Hdfc Bank Limited	₹15.00 Cr	Open
05 Jul 2013	Canara Bank	₹1.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Premas Biotech?

Premas Biotech has a workforce of 109 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Premas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premas Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Premas Biotech

Recent Activity within the Organization

Charges

Progress on A charge with Hdfc Bank Limited of Rs. 15.00 Cr registered on 11 Mar 2022 with Charge ID 100551287 was modified on 07 Oct 2025. was documented.
07 Oct 2025
Charges

A charge with Hdfc Bank Limited of Rs. 15.00 Cr registered on 07 Sep 2021 with Charge ID 100503285 was modified on 07 Oct 2025. was recorded as a recent event.
07 Oct 2025
Annual General Meeting

The activity Premas Biotech Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was completed.
05 Sep 2025
Balance Sheet

Premas Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
31 Mar 2025
Charges

A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 2.00 Cr with Charge ID 100611565 was registered on 16 Sep 2022. was recorded as a recent event.
16 Sep 2022
Director Appointment

Progress on Saumen Chakraborty was appointed as a Director was appointed as a Director on 29 Apr 2022 & has been associated with this company since 3 years 9 months . was documented.
29 Apr 2022

Explore recent activity and updates - View Recent Activity